Publication | Closed Access
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis.
39
Citations
0
References
1998
Year
No significant improvement in RA after murine anti-CD4 Mab was observed.